Paragon 28, Inc. (NYSE:FNA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the company, Ratings reports. Four research analysts have ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.5glegtPn.js ...

Paragon 28, Inc. (FNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its ...

Stephens analysts adjusted their stance on Paragon 28 , Inc. (NYSE:FNA), downgrading the stock from Overweight to Equal ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.4, a ...

Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be ...

William Blair has recently reduced Paragon 28 Inc (FNA) stock to Mkt Perform rating, as announced on Today, according to Finviz. Earlier, on Today, Needham had reduced the stock from a Buy to Hold.

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...

Zimmer Biomet Holdings (ZBH) and Paragon 28 (FNA) announced they have entered into a definitive agreement for Zimmer Biomet to acquire all ...

Paragon 28 shares rose 8.4% after Zimmer Biomet Holdings agreed to acquire the company. Shares were trading around $13.02. The stock is up about 2.6% over the last year.

Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...